| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $472.50 | $494.76 | $590.63 | |
Kaiser Permanente
| Professional | $519.75 | $567.00 | $661.50 | |
United
| Professional | $635.09 | $734.76 | $784.62 |
Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
HMSA
| Professional | $472.50 | $494.76 | $590.63 | |
Kaiser Permanente
| Professional | $519.75 | $567.00 | $661.50 | |
United
| Professional | $635.09 | $734.76 | $784.62 |